Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Intravesical Epirubicin After Radical Nephroureterectomy for UTUC
NCT02438865Phase 2Completed
- Sponsor
- Mansoura University
- Start
- Jan 2015
- Primary completion
- May 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of epirubicin in upper tract urothelial carcinoma (UTUC), sponsored by Mansoura University. Started Jan 2015; status: completed.
02
Drugs
epirubicin
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT02438865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02438865.